pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Rare Disease · news · pharmadog
← back to Rare Disease
News · Rare Disease
856
stories
Jun 26, 26
On second try, Acadia drug gets nod from European regulators
biopharma dive
Jun 25, 26
De-Risking a Rare Disease Launch Starts with Precision
fiercebiotech
Jun 20, 26
Endpoints News History: 10 Years, Bootstrap to FT
endpoints
Jun 19, 26
Federal grant delays could jeopardize essential disability services, research
stat
Jun 18, 26
Moderna flu vaccine wins unanimous support from FDA panel
biopharma dive
Jun 18, 26
New hope in treating Huntington’s disease and a report card on RFK Jr.’s promises
stat
Jun 18, 26
Ebola cases increase almost 40% in a week as death toll passes 200
stat
Jun 17, 26
UniQure to file gene therapy for approval, reflecting major shifts at FDA
biopharma dive
Jun 15, 26
FDA plans to keep Makary priorities on trials, China, deputy says
endpoints
Jun 15, 26
Covid vaccination cut risk of adverse heart events, large study finds
stat
Jun 15, 26
Lilly scores early positive data for new JAK drug
biopharma dive
Jun 13, 26
STAT+: FDA approves Sanofi diabetes drug for children with stage 3 diabetes
stat
Jun 13, 26
WHO director-general is profoundly concerned after visit to Ebola outbreak area
stat
Jun 12, 26
Amgen and the FDA want two different outcomes for Tavneos. What will patients do?
endpoints
Jun 12, 26
Biopharma's pay oddities of 2025: Executive perks and eccentricities
endpoints
Jun 12, 26
STAT+: Pharmalittle: We’re reading about a discontinued cancer drug, a Novo security breach, and more
stat
Jun 11, 26
Drinking during pregnancy rose after 2020, new CDC data suggest
stat
Jun 11, 26
Nonprofit buys experimental cancer drug to maintain patient access
stat
Jun 11, 26
Sensorion, citing Regeneron competition, shifts focus to a different hearing loss therapy
biopharma dive
Jun 11, 26
Novartis RNA drug acquired in $12B Avidity deal notches a trial win
biopharma dive
Jun 11, 26
J&J looks to widen Imaavy’s use; $300M backs rare disease drug launch
biopharma dive
Jun 10, 26
Rare disease biotech Beren adds $300M from new financings
endpoints
Jun 10, 26
Sanofi stops immune drug trial in latest research setback
biopharma dive
Jun 10, 26
STAT+: Hope for Kendall Square’s lab market
stat
Jun 10, 26
DOJ reaches second settlement on youth gender care
stat
Jun 10, 26
Sanofi to mull riliprubart’s future after stopping late-stage nerve disease study
endpoints
Jun 9, 26
Grace Science says FDA bottleneck jeopardizes rare disease therapy
endpoints
Jun 8, 26
Health workers at the epicenter of Congo’s Ebola outbreak labor with little pay or rest
stat
Jun 8, 26
STAT+: J&J spends $1 billion to enter KRAS race for cancer treatments
stat
Jun 6, 26
Opinion: How the Amish think about vaccines, health care costs, and much more
stat
← prev
page 23 of 29
next →
